AstraZeneca and University of Oxford are working on modification of the existing Covid-19 vaccine Covishield in India to become effective against the South African coronavirus.
AstraZeneca’s Austria country manager, Sarah Walters said in an interview that the vaccine is expected to be ready by the end of the year.
